Pharma Firm Eyes Yearly Savings of ₹11.5 Million with Rooftop Solar Leasing

Two Point O’s rooftop leasing solution is 82% cheaper than grid power

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights

Facing high electricity costs and unreliable power supply, a leading pharmaceutical company in Himachal Pradesh’s Baddi saw a way out with a customized 1.122 MW rooftop solar leasing solution.

Developed by Two Point O Capital, the solution had the potential to reduce costs with cheaper power and more reliability.

Six months since its installation, the company is looking to trim its power costs by ₹11.5 million (~$120,679) annually.

The solution is 82% cheaper than grid power and 66% cheaper than the power purchase agreement (PPA) alternative.

The rooftop solar system was installed by Two Point O in December last year. The company would have to pay ₹5.7 (~$0.0598)/kWh for the first five years, after which the solar asset would be transferred to it at zero cost.

High-efficiency TOPCon 610 modules, preferred by commercial and industrial enterprises, were used in the project.

The pharmaceutical company needed a solution that could deliver assured savings, more control over generation, and reliable operations without creating an upfront CAPEX burden.

Without the leasing solution, grid power is expected to cost an average of ₹9.9 (~$0.104)/kWh over 20 years, translating into a total electricity cost of ₹285 million (~$2.99 million).

An open-access PPA would have cost the company approximately ₹5.2 (~$0.0546)/kWh, but it had limitations regarding asset quality, generation control, and long-term accountability.

With its five-year rooftop solar leasing solution, Two Point O Capital will take responsibility for the equipment, installation, commissioning, annual maintenance, and ongoing generation performance.